• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TAC124020A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Ischemia (1942)
Date of Event 09/11/2022
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2022, the patient underwent emergency treatment of a symptomatic zone 0 dissecting aneurysm using gore® tag® thoracic branch endoprostheses (tbe) and gore® tag® conformable thoracic stent grafts with active control system.A gore® dryseal flex introducer sheath and a gore® tri-lobe balloon catheter were used as accessories in the procedure.The patient's anatomy was reported to be extensively tortuous.On (b)(6) 2022, the gore representative was made aware that the patient had spinal cord ischemia which was observed on the evening of the index procedure.It was reported that a non-prophylactic spinal drain was placed post-procedure and a plan was made to discharge the patient to a rehab center.The spinal cord ischemia is ongoing.On (b)(6) 2022, it was reported that the patient's symptoms are improving.
 
Additional Manufacturer Narrative
Additional devices included on this report are as follows: catalog #tsb121506a/ serial #(b)(4), udi #(b)(4) as the same system of components.Catalog #tgmr373720/ serial #(b)(4), udi #(b)(4).Catalog #ttgmr313120/ serial #(b)(4), udi #(b)(4).Catalog #bcl2645/ serial #(b)(4), udi #(b)(4).Catalog #dsf2665/ serial #(b)(4), udi #(b)(4).(b)(4).According to the gore® tag® thoracic branch endoprosthesis instructions for use, potential adverse events and complications that may occur with the use of the gore® tag® thoracic branch endoprosthesis include, but are not limited to, embolism (micro and macro) with transient or permanent ischemia, peripheral malperfusion or ischemia, and neurologic damage, local or systemic (e.G., stroke, paraplegia, paraparesis).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Additional Manufacturer Narrative
H.6.Investigation conclusions code d15 and d12 remain unchanged.Upon review of the event by the product specialist it was determined that the tsb121506a (serial #(b)(6)) gore® tag® thoracic branch endoprosthesis - side branch did not cause or contribute to the spinal cord ischemia event.As there are no allegations of deficiency against the side branch device, this device will not be included in the report or investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
jenna lopez
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15592755
Report Number2017233-2022-03398
Device Sequence Number16723222
Product Code MIH
UDI-Device Identifier00733132654246
UDI-Public00733132654246
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P210032
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/18/2024
Device Model NumberTAC124020A
Device Catalogue NumberTAC124020A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/12/2022
Supplement Date Received by Manufacturer02/08/2023
Initial Report FDA Received Date10/12/2022
Supplement Report FDA Received Date02/08/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/20/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexMale
-
-